Reuters logo
BRIEF-Pharma Mar unit presents positive results for lung cancer‍​ diagnostic kit
September 11, 2017 / 11:34 AM / 2 months ago

BRIEF-Pharma Mar unit presents positive results for lung cancer‍​ diagnostic kit

Sept 11 (Reuters) - PHARMA MAR SA:

* ITS UNIT GENOMICA PRESENTS POSITIVE RESULTS FOR ITS CLART CMA EGFR DIAGNOSTIC KIT FOR NON-SMALL CELL LUNG CANCER (NSCLC) FOR HOSPITAL USE‍​

* SAYS PRESENTED DATA FOR DIAGNOSTIC KIT CONFIRMS SENSITIVITY OF 100 PERCENT AND SPECIFICITY OF 96.5 PERCENT Source text: bit.ly/2jihc6D

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below